SCHEMBL6175032

SCHEMBL6175032

CC1(Cc2ccnc(NC(=O)NCc3ccccc3)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.43
NAMPT P43490 4/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
EPHX2 P34913 3/20 0.40
PTGS2 P35354 1/20 0.40
IGF1R P08069 2/20 0.40
GSK3B P49841 1/20 0.40
TRPV1 Q8NER1 2/20 0.40
KCNH2 Q12809 1/20 0.39
SCN5A Q14524 1/20 0.39
SCN9A Q15858 1/20 0.39
PPARA Q07869 2/20 0.39
KIT P10721 1/20 0.39
BRAF P15056 1/20 0.39
MET P08581 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173728 0.92 MEN1 (0.47) NAMPTMEN1KMT2AEPHX2PTGS2
SCHEMBL6171765 0.89 IGF1R (0.41) MEN1KMT2AEPHX2PTGS2IGF1R
SCHEMBL6173969 0.87 IGF1R (0.55) MAPK1IGF1R
SCHEMBL6176511 0.86 NAMPT (0.43) MAPK1NAMPTIGF1RKITBRAF
SCHEMBL6172735 0.85 IGF1R (0.42) EPHX2IGF1R
SCHEMBL6177003 0.85 TDP1 (0.42) KMT2AIGF1RGSK3BKITBRAF
SCHEMBL6175034 0.85 IGF1R (0.40) MAPK1NAMPTKMT2AEPHX2PTGS2
SCHEMBL6177217 0.85 TLR7 (0.39) NAMPTIGF1RTRPV1
SCHEMBL6173624 0.85 IGF1R (0.42) MAPK1NAMPTIGF1R
SCHEMBL6172079 0.84 IGF1R (0.47) KMT2AIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed